Status: current, Defined. Date: 31-May 2013. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2966271000168115 | Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2966281000168117 | Caelyx 20 mg/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Caelyx 20 mg/10 mL injection, 10 mL vial | has TPUU | True | Caelyx 20 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Caelyx 20 mg/10 mL injection, 10 mL vial | has TPUU | True | Caelyx 20 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Caelyx 20 mg/10 mL injection, 10 x 10 mL vials | has TPUU | True | Caelyx 20 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | has TPUU | True | Caelyx 20 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set